Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV Infection

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The primary objectives of this study are to evaluate the efficacy, safety and tolerability of treatment with sofosbuvir (SOF)+ ribavirin (RBV), with or without Pegylated interferon alfa (Peg-IFNα-2a/ PEG)) in participants with chronic genotype (GT)-1, 2, 3, and 6 Hepatitis C virus (HCV) infection.
Epistemonikos ID: 51c241ac692c8632e3e409831e5d29c4192ac162
First added on: May 11, 2024